Skip to main content

Control of nausea and vomiting after chemotherapy: what is the evidence?

Buy Article:

$51.00 plus tax (Refund Policy)



The control of nausea and vomiting is an important problem for patients undergoing chemotherapy. With the introduction of newer agents, including 5-HT3 antagonists, nausea and vomiting control after chemotherapy has much improved but is not always optimal. While there is an intrinsic limitation to the efficacy of anti-emetic drugs, their efficacy can be further reduced if the drugs are not used appropĀ­riately. In some circumstances newer anti-emetics may be unnecessary and better nausea and vomiting control may be established by use of older agents. This paper summarizes current evidence regarding the optimal approach to management of nausea and vomiting in patients undergoing chemotherapy. (Intern Med J 2002; 32: 401−407)

Keywords: chemotherapy; nausea; vomiting

Document Type: Research Article


Affiliations: Department of Medical Oncology, Flinders Medical Centre, Adelaide, South Australia, Australia

Publication date: August 1, 2002


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more